Resolvex Pharmaceuticals Inc.
$50,000.00 CAD
≈ 8 months of average Canadian pay
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2018-2019
- Agreement period
- April 1, 2018 – March 31, 2019
- Reference
- nrc-cnrc:172-2018-2019-Q3-904288
Published purpose
This aim of this project is to determine the oral bioavailability and ADME properties of RLV-102 and develop a locally deliverable formulation (intestine/colon) for use as an oral therapeutic agent for inflammatory bowel disease.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported July 30, 2026 from open.canada.ca Grants & Contributions